Anat Ben-Shlomo
-
- Pituitary Gland Disorders and Treatments 50
- Growth Hormone and Insulin-like Growth Factors 30
- Adrenal Hormones and Disorders 11
- Hormonal Regulation and Hypertension 6
- Genetics top 2%
- Glioma Diagnosis and Treatment 8
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 18
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 9
- Surgery top 5%
- Adrenal and Paraganglionic Tumors 9
- Co-authors
- Шломо МелмедOdelia CooperKolja WawrowskyVera ChesnokovaSvetlana ZonisSong-Guang RenNing‐Ai LiuAdam N. Mamelak
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesIsraelSwitzerland
In The Last Decade
Anat Ben-Shlomo
70 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 114
- Endocrinology, Diabetes and Metabolism 1.7k
- Genetics 408
- Epidemiology 617
- Cancer Research 232
- Surgery 682
Countries citing papers authored by Anat Ben-Shlomo
This map shows the geographic impact of Anat Ben-Shlomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anat Ben-Shlomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anat Ben-Shlomo more than expected).
Fields of papers citing papers by Anat Ben-Shlomo
This network shows the impact of papers produced by Anat Ben-Shlomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anat Ben-Shlomo. The network helps show where Anat Ben-Shlomo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anat Ben-Shlomo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 16 | |
| 5 | 2022 | 10 | |
| 6 | 2021 | 21 | |
| 7 | 2021 | 23 | |
| 8 | 2021 | 6 | |
| 9 | 2018 | 89 | |
| 10 | 2016 | 2 | |
| 11 | 2011 | 97 | |
| 12 | 2011 | 39 | |
| 13 | 2010 | 9 | |
| 14 | 2008 | 16 | |
| 15 | 2007 | 81 | |
| 16 | Pasireotide--a somatostatin analog for the potential treatment of acromegaly, neuroendocrine tumors and Cushing's disease. | 2007 | 33 |
| 17 | 2006 | 50 | |
| 18 | 2005 | 55 | |
| 19 | 2001 | 1 | |
| 20 | 2001 | 18 |
About Anat Ben-Shlomo
Anat Ben-Shlomo is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Cancer Research, having authored 72 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (50 papers), Growth Hormone and Insulin-like Growth Factors (30 papers), Neuroendocrine Tumor Research Advances (18 papers), Adrenal Hormones and Disorders (11 papers), Adrenal and Paraganglionic Tumors (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), Glioma Diagnosis and Treatment (8 papers) and Hormonal Regulation and Hypertension (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Genetics (408 citations) and Epidemiology (617 citations). Anat Ben-Shlomo has collaborated with scholars based in United States, Israel and Switzerland. Frequent co-authors include Шломо Мелмед, Odelia Cooper, Kolja Wawrowsky, Vera Chesnokova, Svetlana Zonis, Song-Guang Ren, Ning‐Ai Liu, Adam N. Mamelak, Philippe Hagag and Serguei Bannykh. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.